Sandip Kumar Basu - Revision history

Md: general update intro after review and fixed typos per sources

2025-09-24T23:16:59Z

general update intro after review and fixed typos per sources

← Older revision		Revision as of 04:46, 25 September 2025
Line 1:		Line 1:
			{{Short description\|Indian molecular biologist}}
	{{Use dmy dates\|date=May 2018}}		{{Use dmy dates\|date=May 2018}}
	{{Use Indian English\|date=May 2018}}		{{Use Indian English\|date=May 2018}}
	{{Infobox person		{{Infobox person
	\| name = Sandip Kumar Basu		\| name = Sandip Kumar Basu
	\| image =		\| image =
	\| imagesize =		\| imagesize =
	\| caption =		\| caption =
	\| birth_date = 1944		\| birth_date = {{Birth year and age\|1944}}
	\| birth_place = [[Kolkata]], [[West Bengal]], India		\| birth_place = [[Kolkata]], [[West Bengal]], India
	\| death_date =		\| death_date =
	\| death_place =		\| death_place =
	\| restingplace =		\| restingplace =
	\| restingplacecoordinates =		\| restingplacecoordinates =
	\| othername =		\| othername =
	\| occupation =		\| occupation =
	\| yearsactive = since 1975		\| yearsactive = since 1975
	\| known for =		\| known for =
	\| spouse =		\| spouse =
	\| domesticpartner =		\| domesticpartner =
	\| children =		\| children =
	\| parents =		\| parents =
	\| website =		\| website =
	\| awards = [[Padma Shri]]<br>[[Ranbaxy]] Medical Sciences Award<br>[[FICCI]] Life Sciences Award<br>Bhasin Foundation Biotechnology Award<br>[[Indian Council of Medical Research\|ICMR]] B. R. Ambedkar Award<br>ISCA R. K. Dutt Memorial Award<br>Goyal Prize		\| awards = [[Padma Shri]]<br>[[Ranbaxy]] Medical Sciences Award<br>[[FICCI]] Life Sciences Award<br>Bhasin Foundation Biotechnology Award<br>[[Indian Council of Medical Research\|ICMR]] B. R. Ambedkar Award<br>ISCA R. K. Dutt Memorial Award<br>Goyal Prize

	}}		}}
	'''Sandip Kumar Basu''' (born 1944) is an Indian molecular biologist and the holder of the J. C. Bose Chair of the [[National Academy of Sciences, India]], who is credited with innovations in the treatment protocols of [[leishmaniasis]], [[tuberculosis]], viral infections, multidrug resistant cancer and [[arterosclerosis]].<ref name="INSA">{{cite web \| url=http://insaindia.org.in/detail.php?id=N94-1140 \| title=INSA \| publisher=INSA \| date=2014 \| access-date=5 January 2015}}</ref> He was honored by the [[Government of India]], in 2001, with the fourth highest [[Indian honours system\|Indian civilian award]] of [[Padma Shri]].<ref name="Padma Awards">{{cite web \| url=http://mha.nic.in/sites/upload_files/mha/files/LST-PDAWD-2013.pdf \| title=Padma Awards \| publisher=Padma Awards \| date=2014 \| access-date=11 November 2014}}</ref>		'''Sandip Kumar Basu''' (born 1944) is an Indian molecular biologist and the holder of the J. C. Bose Chair of the [[National Academy of Sciences, India]], who is credited with innovations in the treatment protocols of [[leishmaniasis]], [[tuberculosis]], viral infections, multidrug resistant cancer and [[arterosclerosis]].<ref name="INSA">{{cite web \| url=http://insaindia.org.in/detail.php?id=N94-1140 \| archive-url=https://web.archive.org/web/20160812222652/http://insaindia.org.in/detail.php?id=N94-1140 \| url-status=usurped \| archive-date=12 August 2016 \| title=INSA \| publisher=INSA \| date=2014 \| access-date=5 January 2015}}</ref> He was honored by the [[Government of India]], in 2001, with the fourth highest [[Indian honours system\|Indian civilian award]] of [[Padma Shri]].<ref name="Padma Awards">{{cite web \| url=http://mha.nic.in/sites/upload_files/mha/files/LST-PDAWD-2013.pdf \| title=Padma Awards \| publisher=Padma Awards \| date=2014 \| access-date=11 November 2014 \| archive-date=15 October 2015 \| archive-url=https://web.archive.org/web/20151015193758/http://mha.nic.in/sites/upload_files/mha/files/LST-PDAWD-2013.pdf \| url-status=dead }}</ref>

	==Biography==		==Biography==
	Sandip Kumar Basu was born in Kolkata in the Indian state of West Bengal.<ref name="INSA" /> He graduated in 1962 from the [[Presidency College, Calcutta]] and secured his master's degree in 1964 from the [[Rajabazar Science College\|University College of Science]]. His doctoral research was at the [[Calcutta University]] which he successfully completed in 1968 on the topic, ''regulation of microbial metabolism'' and moved to USA for post doctoral research at [[Keck School of Medicine of USC]], Los Angeles, [[University of California, Irvine School of Medicine]], [[Public Health Research Institute]], New York and [[Michael Reese Hospital]], Chicago.<ref name="INSA" /> In 1975, he started his professional career by joining the [[University of Texas Southwestern Medical School]] as a faculty member and stayed there till 1983 when he returned to India to join the [[Indian Institute of Chemical Biology]], Kolkata. His next move was as the director of the [[Institute of Microbial Technology]], Chandigarh in 1986.<ref name="INSA" /> He became the director of the [[National Institute of Immunology, India\|National Institute of Immunology]], New Delhi in 1991, a post he held till 2005 when he became the Professor of Eminence of the institute and continued there till 2010. He is the [[J. C. Bose]] Chair Professor of the [[National Academy of Sciences, India]], placed at the [[National Institute of Science Communication and Information Resources]] of the [[Council of Scientific and Industrial Research]].<ref name="INSA" />		Sandip Kumar Basu was born in [[Kolkata]] in the Indian state of [[West Bengal]].<ref name="INSA" /> He graduated in 1962 from the [[Presidency College, Calcutta]] and secured his master's degree in 1964 from the [[Rajabazar Science College\|University College of Science]]. His doctoral research was at the [[Calcutta University]] which he successfully completed in 1968 on the topic, ''regulation of [[Microorganism\|microbial]] [[metabolism]]'' and moved to USA for post doctoral research at [[Keck School of Medicine of USC]], Los Angeles, [[University of California, Irvine School of Medicine]], [[Public Health Research Institute]], New York and [[Michael Reese Hospital]], Chicago.<ref name="INSA" /> In 1975, he started his professional career by joining the [[University of Texas Southwestern Medical School]] as a faculty member and stayed there till 1983 when he returned to India to join the [[Indian Institute of Chemical Biology]], Kolkata. His next move was as the director of the [[Institute of Microbial Technology]], Chandigarh in 1986.<ref name="INSA" /> He became the director of the [[National Institute of Immunology, India\|National Institute of Immunology]], New Delhi in 1991, a post he held till 2005 when he became the Professor of Eminence of the institute and continued there till 2010. He is the [[J. C. Bose]] Chair Professor of the [[National Academy of Sciences, India]], placed at the [[National Institute of Science Communication and Information Resources]] of the [[Council of Scientific and Industrial Research]].<ref name="INSA" />

	Basu has been involved with research on the receptor based intracellular delivery of drugs.<ref name="ResearchGate">{{cite web \| url=https://www.researchgate.net/profile/Sandip_Basu5 \| title=ResearchGate \| date=2014 \| access-date=5 January 2015}}</ref><ref name="NISCAIR">{{cite web \| url=http://nopr.niscair.res.in/handle/123456789/39/items-by-author?author=Basu%2C+Sandip+Kumar \| title=NISCAIR \| publisher=NISCAIR \| date=2014 \| access-date=5 January 2015}}</ref><ref name="Microsoft Academic Search">{{cite web \| url=http://libra.msra.cn/PublicationList?srcType=4&desType=2&srcID=7767&desID=52290139 \| title=Microsoft Academic Search \| publisher=Microsoft Academic Search \| date=2014 \| access-date=5 January 2015}}</ref><ref name="PubFacts">{{cite web \| url=http://www.pubfacts.com/author/Sandip+Kumar+Basu \| title=PubFacts \| publisher=PubFacts \| date=2014 \| access-date=5 January 2015}}</ref> He is known to have introduced a new approach of ''scavenger receptor-mediated targeting of therapeutic agents'' which has been demonstrated to be more effective than conventional [[chemotherapy]], in the treatment of [[leishmaniasis]], [[tuberculosis]], viral infections, and multidrug resistant cancer.<ref name="INSA" /> His research has led to the discovery of new drug targets and also demonstrated the therapeutic effect of immunomodulator muramyl dipeptide on [[salmonella]] by diverting the route the pathogens follow so as to survive within the [[macrophages]].<ref name="INSA" /> He is credited with the establishment of the pathway of [[low density lipoprotein]] receptors.<ref name="The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages">{{cite journal \| title=The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages \|author1=Michael S Brown \|author2=Sandip K Basu \|author3=JR Falck \|author4=YK Ho \|author5=Joseph L Goldstein \| journal=Journal of Supramolecular Structure \| year=1980 \| volume=13 \| issue=1 \| pages=67–81 \| doi=10.1002/jss.400130107\|pmid = 6255257}}</ref><ref>{{Cite journal \|doi = 10.1073/pnas.76.1.333\|pmid = 218198\|pmc = 382933\|title = Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition\|journal = Proceedings of the National Academy of Sciences\|volume = 76\|issue = 1\|pages = 333–337\|year = 1979\|last1 = Goldstein\|first1 = J. L.\|last2 = Ho\|first2 = Y. K.\|last3 = Basu\|first3 = S. K.\|last4 = Brown\|first4 = M. S.\|bibcode = 1979PNAS...76..333G}}</ref> It is reported that Basu's work assisted [[Michael Stuart Brown]] and [[Joseph L. Goldstein]], 1985 [[Nobel Prize]] winners and his co-authors, in their research and in the development of [[statins]], the cholesterol lowering drug.<ref name="INSA" /><ref name="Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans">{{cite journal \| title=Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans \|author1=Goldstein JL \|author2=Basu SK \|author3=Brunschede GY \|author4=Brown MS \| journal=Cell \|date=January 1976 \| volume=7 \| issue=1 \| pages=85–95 \| pmid=181140 \| doi=10.1016/0092-8674(76)90258-0 \|s2cid=23110979 }}</ref><ref name="Google Scholar">{{cite web \| url=https://scholar.google.com/citations?user=XATuveIAAAAJ&hl=en \| title=Google Scholar \| publisher=Google Scholar \| date=2014 \| access-date=5 January 2015}}</ref>		Basu has been involved with research on the receptor based [[Drug delivery\|intracellular delivery of drugs]].<ref name="ResearchGate">{{cite web \| url=https://www.researchgate.net/profile/Sandip_Basu5 \| title=ResearchGate \| date=2014 \| access-date=5 January 2015}}</ref><ref name="NISCAIR">{{cite web \| url=http://nopr.niscair.res.in/handle/123456789/39/items-by-author?author=Basu%2C+Sandip+Kumar \| title=NISCAIR \| publisher=NISCAIR \| date=2014 \| access-date=5 January 2015}}</ref><ref name="Microsoft Academic Search">{{cite web \| url=http://libra.msra.cn/PublicationList?srcType=4&desType=2&srcID=7767&desID=52290139 \| title=Microsoft Academic Search \| publisher=Microsoft Academic Search \| date=2014 \| access-date=5 January 2015}}</ref><ref name="PubFacts">{{cite web \| url=http://www.pubfacts.com/author/Sandip+Kumar+Basu \| title=PubFacts \| publisher=PubFacts \| date=2014 \| access-date=5 January 2015}}</ref> He is known to have introduced a new approach of ''[[Scavenger receptor (immunology)\|scavenger receptor]]-mediated targeting of therapeutic agents'' which has been demonstrated to be more effective than conventional [[chemotherapy]], in the treatment of [[leishmaniasis]], [[tuberculosis]], viral infections, and multidrug resistant cancer.<ref name="INSA" /> His research has led to the discovery of new drug targets and also demonstrated the therapeutic effect of immunomodulator muramyl dipeptide on [[salmonella]] by diverting the route the pathogens follow so as to survive within the [[macrophages]].<ref name="INSA" /> He is credited with the establishment of the pathway of [[low density lipoprotein]] receptors.<ref name="The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages">{{cite journal \| title=The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages \|author1=Michael S Brown \|author2=Sandip K Basu \|author3=JR Falck \|author4=YK Ho \|author5=Joseph L Goldstein \| journal=Journal of Supramolecular Structure \| year=1980 \| volume=13 \| issue=1 \| pages=67–81 \| doi=10.1002/jss.400130107\|pmid = 6255257}}</ref><ref>{{Cite journal \|doi = 10.1073/pnas.76.1.333\|pmid = 218198\|pmc = 382933\|title = Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition\|journal = Proceedings of the National Academy of Sciences\|volume = 76\|issue = 1\|pages = 333–337\|year = 1979\|last1 = Goldstein\|first1 = J. L.\|last2 = Ho\|first2 = Y. K.\|last3 = Basu\|first3 = S. K.\|last4 = Brown\|first4 = M. S.\|bibcode = 1979PNAS...76..333G\|doi-access = free}}</ref> It is reported that Basu's work assisted [[Michael Stuart Brown]] and [[Joseph L. Goldstein]], 1985 [[Nobel Prize]] winners and his co-authors, in their research and in the development of [[statins]], the cholesterol lowering drug.<ref name="INSA" /><ref name="Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans">{{cite journal \| title=Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans \|author1=Goldstein JL \|author2=Basu SK \|author3=Brunschede GY \|author4=Brown MS \| journal=Cell \|date=January 1976 \| volume=7 \| issue=1 \| pages=85–95 \| pmid=181140 \| doi=10.1016/0092-8674(76)90258-0 \|s2cid=23110979 }}</ref><ref name="Google Scholar">{{cite web \| url=https://scholar.google.com/citations?user=XATuveIAAAAJ&hl=en \| title=Google Scholar \| publisher=Google Scholar \| date=2014 \| access-date=5 January 2015}}</ref>

	Basu is also credited with administrative achievements such as the establishment of a permanent campus at the [[Institute of Microbial Technology]], Chandigarh.<ref name="INSA" /> A former member of the Scientific Advisory Committee to the [[Government of India]], he has served as the council member of [[Indian National Science Academy]], the [[Indian Academy of Sciences]] and [[National Academy of Sciences, India]] and has also been the general secretary and vice president of NASI.<ref name="INSA" />		Basu is also credited with administrative achievements such as the establishment of a permanent campus at the [[Institute of Microbial Technology]], Chandigarh.<ref name="INSA" /> A former member of the Scientific Advisory Committee to the [[Government of India]], he has served as the council member of [[Indian National Science Academy]], the [[Indian Academy of Sciences]] and [[National Academy of Sciences, India]] and has also been the general secretary and vice president of NASI.<ref name="INSA" />
Line 50:		Line 50:
	* {{cite journal \| title=The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages \|author1=Michael S Brown \|author2=Sandip K Basu \|author3=JR Falck \|author4=YK Ho \|author5=Joseph L Goldstein \| journal=Journal of Supramolecular Structure \| year=1980 \| volume=13 \| issue=1 \| pages=67–81 \| doi=10.1002/jss.400130107\|pmid = 6255257}}		* {{cite journal \| title=The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages \|author1=Michael S Brown \|author2=Sandip K Basu \|author3=JR Falck \|author4=YK Ho \|author5=Joseph L Goldstein \| journal=Journal of Supramolecular Structure \| year=1980 \| volume=13 \| issue=1 \| pages=67–81 \| doi=10.1002/jss.400130107\|pmid = 6255257}}

	{{Padma Shri Award Recipients in Science & Engineering}}		{{2000s Padma Shri Award Recipients in Science & Engineering}}
	{{authority control}}		{{authority control}}

Line 60:		Line 60:
	[[Category:Living people]]		[[Category:Living people]]
	[[Category:Indian molecular biologists]]		[[Category:Indian molecular biologists]]
	[[Category:Fellows of ~~The~~ National Academy of Sciences, India]]		[[Category:Fellows of the National Academy of Sciences, India]]
	[[Category:Fellows of the Indian Academy of Sciences]]		[[Category:Fellows of the Indian Academy of Sciences]]
	[[Category:Fellows of the Indian National Science Academy]]		[[Category:Fellows of the Indian National Science Academy]]
	[[Category:20th-century Indian biologists]]		[[Category:20th-century Indian biologists]]

imported>Monkbot: Task 18 (cosmetic): eval 15 templates: hyphenate params (10×);

2021-01-01T03:43:08Z

Task 18 (cosmetic): eval 15 templates: hyphenate params (10×);

New page

{{Use dmy dates|date=May 2018}}
{{Use Indian English|date=May 2018}}
{{Infobox person
| name = Sandip Kumar Basu
| image =
| imagesize =
| caption =
| birth_date = 1944
| birth_place = [[Kolkata]], [[West Bengal]], India
| death_date =
| death_place =
| restingplace =
| restingplacecoordinates =
| othername =
| occupation =
| yearsactive = since 1975
| known for =
| spouse =
| domesticpartner =
| children =
| parents =
| website =
| awards = [[Padma Shri]] [[Ranbaxy]] Medical Sciences Award [[FICCI]] Life Sciences Award Bhasin Foundation Biotechnology Award [[Indian Council of Medical Research|ICMR]] B. R. Ambedkar Award ISCA R. K. Dutt Memorial Award Goyal Prize

}}
'''Sandip Kumar Basu''' (born 1944) is an Indian molecular biologist and the holder of the J. C. Bose Chair of the [[National Academy of Sciences, India]], who is credited with innovations in the treatment protocols of [[leishmaniasis]], [[tuberculosis]], viral infections, multidrug resistant cancer and [[arterosclerosis]].<ref name="INSA">{{cite web | url=http://insaindia.org.in/detail.php?id=N94-1140 | title=INSA | publisher=INSA | date=2014 | access-date=5 January 2015}}</ref> He was honored by the [[Government of India]], in 2001, with the fourth highest [[Indian honours system|Indian civilian award]] of [[Padma Shri]].<ref name="Padma Awards">{{cite web | url=http://mha.nic.in/sites/upload_files/mha/files/LST-PDAWD-2013.pdf | title=Padma Awards | publisher=Padma Awards | date=2014 | access-date=11 November 2014}}</ref>

==Biography==
Sandip Kumar Basu was born in Kolkata in the Indian state of West Bengal.<ref name="INSA" /> He graduated in 1962 from the [[Presidency College, Calcutta]] and secured his master's degree in 1964 from the [[Rajabazar Science College|University College of Science]]. His doctoral research was at the [[Calcutta University]] which he successfully completed in 1968 on the topic, ''regulation of microbial metabolism'' and moved to USA for post doctoral research at [[Keck School of Medicine of USC]], Los Angeles, [[University of California, Irvine School of Medicine]], [[Public Health Research Institute]], New York and [[Michael Reese Hospital]], Chicago.<ref name="INSA" /> In 1975, he started his professional career by joining the [[University of Texas Southwestern Medical School]] as a faculty member and stayed there till 1983 when he returned to India to join the [[Indian Institute of Chemical Biology]], Kolkata. His next move was as the director of the [[Institute of Microbial Technology]], Chandigarh in 1986.<ref name="INSA" /> He became the director of the [[National Institute of Immunology, India|National Institute of Immunology]], New Delhi in 1991, a post he held till 2005 when he became the Professor of Eminence of the institute and continued there till 2010. He is the [[J. C. Bose]] Chair Professor of the [[National Academy of Sciences, India]], placed at the [[National Institute of Science Communication and Information Resources]] of the [[Council of Scientific and Industrial Research]].<ref name="INSA" />

Basu has been involved with research on the receptor based intracellular delivery of drugs.<ref name="ResearchGate">{{cite web | url=https://www.researchgate.net/profile/Sandip_Basu5 | title=ResearchGate | date=2014 | access-date=5 January 2015}}</ref><ref name="NISCAIR">{{cite web | url=http://nopr.niscair.res.in/handle/123456789/39/items-by-author?author=Basu%2C+Sandip+Kumar | title=NISCAIR | publisher=NISCAIR | date=2014 | access-date=5 January 2015}}</ref><ref name="Microsoft Academic Search">{{cite web | url=http://libra.msra.cn/PublicationList?srcType=4&desType=2&srcID=7767&desID=52290139 | title=Microsoft Academic Search | publisher=Microsoft Academic Search | date=2014 | access-date=5 January 2015}}</ref><ref name="PubFacts">{{cite web | url=http://www.pubfacts.com/author/Sandip+Kumar+Basu | title=PubFacts | publisher=PubFacts | date=2014 | access-date=5 January 2015}}</ref> He is known to have introduced a new approach of ''scavenger receptor-mediated targeting of therapeutic agents'' which has been demonstrated to be more effective than conventional [[chemotherapy]], in the treatment of [[leishmaniasis]], [[tuberculosis]], viral infections, and multidrug resistant cancer.<ref name="INSA" /> His research has led to the discovery of new drug targets and also demonstrated the therapeutic effect of immunomodulator muramyl dipeptide on [[salmonella]] by diverting the route the pathogens follow so as to survive within the [[macrophages]].<ref name="INSA" /> He is credited with the establishment of the pathway of [[low density lipoprotein]] receptors.<ref name="The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages">{{cite journal | title=The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages |author1=Michael S Brown |author2=Sandip K Basu |author3=JR Falck |author4=YK Ho |author5=Joseph L Goldstein | journal=Journal of Supramolecular Structure | year=1980 | volume=13 | issue=1 | pages=67–81 | doi=10.1002/jss.400130107|pmid = 6255257}}</ref><ref>{{Cite journal |doi = 10.1073/pnas.76.1.333|pmid = 218198|pmc = 382933|title = Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition|journal = Proceedings of the National Academy of Sciences|volume = 76|issue = 1|pages = 333–337|year = 1979|last1 = Goldstein|first1 = J. L.|last2 = Ho|first2 = Y. K.|last3 = Basu|first3 = S. K.|last4 = Brown|first4 = M. S.|bibcode = 1979PNAS...76..333G}}</ref> It is reported that Basu's work assisted [[Michael Stuart Brown]] and [[Joseph L. Goldstein]], 1985 [[Nobel Prize]] winners and his co-authors, in their research and in the development of [[statins]], the cholesterol lowering drug.<ref name="INSA" /><ref name="Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans">{{cite journal | title=Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans |author1=Goldstein JL |author2=Basu SK |author3=Brunschede GY |author4=Brown MS | journal=Cell |date=January 1976 | volume=7 | issue=1 | pages=85–95 | pmid=181140 | doi=10.1016/0092-8674(76)90258-0 |s2cid=23110979 }}</ref><ref name="Google Scholar">{{cite web | url=https://scholar.google.com/citations?user=XATuveIAAAAJ&hl=en | title=Google Scholar | publisher=Google Scholar | date=2014 | access-date=5 January 2015}}</ref>

Basu is also credited with administrative achievements such as the establishment of a permanent campus at the [[Institute of Microbial Technology]], Chandigarh.<ref name="INSA" /> A former member of the Scientific Advisory Committee to the [[Government of India]], he has served as the council member of [[Indian National Science Academy]], the [[Indian Academy of Sciences]] and [[National Academy of Sciences, India]] and has also been the general secretary and vice president of NASI.<ref name="INSA" />

== Awards and honors ==
Sandip Kumar Basu is an elected Fellow of the [[Indian National Science Academy]], the [[Indian Academy of Sciences]] (FASc),<ref name="IAS">{{cite web | url=http://repository.ias.ac.in/view/fellows/Basu=3ASandip_Kumar=3A=3A.html | title=IAS | publisher=IAS | date=2014 | access-date=5 January 2015}}</ref> [[The World Academy of Sciences]] (FTWAS),<ref name="TWAS">{{cite web | url=http://twas.org/member/basu-sandip-kumar | title=TWAS | publisher=TWAS | date=2014 | access-date=5 January 2015}}</ref> and the [[National Academy of Sciences, India]] (FNASc).<ref name="NII">{{cite web | url=http://www1.nii.res.in/aboutus/honors | title=NII | publisher=NII | date=2014 | access-date=5 January 2015}}</ref> He delivered the ''Professor MRN Prasad Memorial Award Lecture'' in 1995, the ''Dr. Yellapragada SubbaRow Memorial Award Lecture'' in 2002 and the ''B. K. Bachhawat Award Lecture'' in 2006.<ref name="INSA" /> He received the Ranbaxy Medical Sciences Award in 1995 followed by [[FICCI]] Life Sciences Award in 1996 and Bhasin Foundation Biotechnology Award, the next year. The year 1999 brought him two awards, the B. R. Ambedkar Award of the [[Indian Council of Medical Research]] and the R. K. Dutt Memorial Award of the International Science Congress Associations.<ref name="INSA" /> A recipient of the Goyal Prize in 2003, Basu was awarded the civilian honour of [[Padma Shri]] by the [[Government of India]] in 2001.

==See also==
{{Div col|colwidth=30em}}
* [[Michael Stuart Brown]]
* [[Joseph L. Goldstein]]
{{div col end}}
{{portal|India|Medicine}}

==References==
{{reflist}}

==External links==
* {{cite journal | title=Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans |author1=Goldstein JL |author2=Basu SK |author3=Brunschede GY |author4=Brown MS | journal=Cell |date=January 1976 | volume=7 | issue=1 | pages=85–95 | pmid=181140 | doi=10.1016/0092-8674(76)90258-0 |s2cid=23110979 }}
* {{cite journal | title=The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively‐charged LDL by macrophages |author1=Michael S Brown |author2=Sandip K Basu |author3=JR Falck |author4=YK Ho |author5=Joseph L Goldstein | journal=Journal of Supramolecular Structure | year=1980 | volume=13 | issue=1 | pages=67–81 | doi=10.1002/jss.400130107|pmid = 6255257}}

{{Padma Shri Award Recipients in Science & Engineering}}
{{authority control}}

{{DEFAULTSORT:Basu, Sandip Kumar}}
[[Category:Recipients of the Padma Shri in science & engineering]]
[[Category:1944 births]]
[[Category:Scientists from Kolkata]]
[[Category:Indian biochemists]]
[[Category:Living people]]
[[Category:Indian molecular biologists]]
[[Category:Fellows of The National Academy of Sciences, India]]
[[Category:Fellows of the Indian Academy of Sciences]]
[[Category:Fellows of the Indian National Science Academy]]
[[Category:20th-century Indian biologists]]